Page last updated: 2024-11-02

phenobarbital and Angiogenesis, Pathologic

phenobarbital has been researched along with Angiogenesis, Pathologic in 2 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mahmoud, AM1
Zaki, AR1
Hassan, ME1
Mostafa-Hedeab, G1
Lu, M1
Wu, J1
He, F1
Wang, XL1
Li, C1
Chen, ZN1
Bian, H1

Other Studies

2 other studies available for phenobarbital and Angiogenesis, Pathologic

ArticleYear
Commiphora molmol resin attenuates diethylnitrosamine/phenobarbital-induced hepatocarcinogenesis by modulating oxidative stress, inflammation, angiogenesis and Nrf2/ARE/HO-1 signaling.
    Chemico-biological interactions, 2017, May-25, Volume: 270

    Topics: Animals; Cell Proliferation; Diethylnitrosamine; Disease Models, Animal; Heme Oxygenase-1; Inflammat

2017
Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma.
    Journal of molecular histology, 2015, Volume: 46, Issue:1

    Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Basigin; Carcinogens; Carcinoma, H

2015